H. A. Mylius

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

Dietrich W. Beelen, Rudolf Trenschel, J. Casper et al. · Bone Marrow Transplantation · 2004 · 97 citations

Medicine, Hematology, Immunology +17

Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning

Jochen Casper, Daniel Wolff, Wolfgang Knauf et al. · Journal of Clinical Oncology · 2010 · 94 citations · Full text

Medicine, Hematology, Pharmacology +16

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial

Tapani Ruutu, Liisa Volin, Dietrich W. Beelen et al. · Haematologica · 2011 · 83 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning

J. Casper, Rudolf Trenschel, H. Wandt et al. · Bone Marrow Transplantation · 2011 · 58 citations

Medicine, Hematology, Oncology +11